MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
2235.HK Stock Price Chart
Explore MicroTech Medical (Hangzhou) Co., Ltd. interactive price chart. Choose custom timeframes to analyze 2235.HK price movements and trends.
2235.HK Company Profile
Discover essential business fundamentals and corporate details for MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
19 Oct 2021
Employees
678.00
Website
https://www.microtechmd.comCEO
Pan Zheng
Description
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People's Republic of China and internationally. Its products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. The company is also involved in engineering and technology research experimentation and development activities. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.
2235.HK Financial Timeline
Browse a chronological timeline of MicroTech Medical (Hangzhou) Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 29 Aug 2025
EPS came in at -$0.01 surpassing the estimated -$0.08 by +92.86%, while revenue for the quarter reached $269.49M , beating expectations by +15.35%.
Earnings released on 28 Mar 2025
EPS came in at -$0.06 surpassing the estimated -$0.11 by +39.92%, while revenue for the quarter reached $207.23M , missing expectations by -3.18%.
Earnings released on 30 Aug 2024
EPS came in at -$0.10 falling short of the estimated -$0.05 by -79.91%, while revenue for the quarter reached $161.96M , missing expectations by -2.13%.
Earnings released on 28 Mar 2024
EPS came in at -$0.28 falling short of the estimated -$0.08 by -259.12%, while revenue for the quarter reached $157.62M , missing expectations by -60.87%.
Earnings released on 30 Aug 2023
EPS came in at -$0.05 falling short of the estimated -$0.04 by -9.67%, while revenue for the quarter reached $119.84M , beating expectations by +1.69%.
Earnings released on 28 Mar 2023
EPS came in at -$0.07 surpassing the estimated -$0.10 by +32.72%, while revenue for the quarter reached $115.92M , missing expectations by -60.52%.
Earnings released on 30 Aug 2022
EPS came in at -$0.02 surpassing the estimated -$0.09 by +76.69%, while revenue for the quarter reached $84.08M , missing expectations by -2.00%.
Earnings released on 26 Mar 2022
EPS came in at -$0.09 , while revenue for the quarter reached $112.63M .
Earnings released on 27 Dec 2021
EPS came in at -$0.06 , while revenue for the quarter reached $71.33M .
Earnings released on 31 Dec 2020
EPS came in at -$0.16 , while revenue for the quarter reached $44.70M .
2235.HK Stock Performance
Access detailed 2235.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.